The PROXIMA 2 beamline at Synchrotron SOLEIL recently celebrated its first birthday. It's an occasion to reflect back upon a year of the collaborative work accomplished and its high scientific impact.

PHILADELPHIA – Treating obese mice with the cytokine known as TSLP led to significant abdominal fat and weight loss compared to controls, according to new research published Thursday in Science from ...

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "TSLP Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic information on approved drugs and drug ...

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "TSLP Inhibitors and TSLP Receptor Antagonists: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering. This competitive ...

Tezepelumab-ekko is now approved for chronic rhinosinusitis with nasal polyps (CRSwNP), targeting thymic stromal lymphopoietin and marking its second indication after severe asthma. The phase 3 ...

With a $165 million cash tailwind, Windward Bio is advancing its TSLP challengers to Amgen and AstraZeneca's Tezspire. (valio84sl/iStock/Getty Images Plus) Windward Bio is in full sail with a $165 ...

Swiss biotech Windward Bio is planning to take on some heavyweight rivals with its TSLP-acting drug for inflammatory respiratory and dermatological diseases – a mission that will be helped by adding ...

Treating obese mice with the cytokine known as TSLP led to significant abdominal fat and weight loss compared to controls. The animal model findings support the possibility that increasing sebum ...